Precision Medicine for Diffuse Large B-cell Lymphoma. Academic Article uri icon

Overview

abstract

  • This study demonstrates the clinical utility of a targeted gene sequencing panel "the Lymphopanel," which enables the detection of actionable mutations and subtype-enriched gene alterations in diffuse large B-cell lymphoma that will pave the way to precision therapy era for patients with this form of aggressive lymphoma. Clin Cancer Res; 22(12); 2829-31. ©2016 AACRSee related article by Dubois et al., p. 2919.

publication date

  • March 17, 2016

Research

keywords

  • Lymphoma, Large B-Cell, Diffuse
  • Molecular Targeted Therapy
  • Precision Medicine

Identity

Scopus Document Identifier

  • 84975815253

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-16-0232

PubMed ID

  • 26988247

Additional Document Info

volume

  • 22

issue

  • 12